| Oct 23 |
Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment
|
| Oct 23 |
Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt
|
| Oct 23 |
Abbott Laboratories: Promising Growth, Yet Fully Valued; A Wait-And-Watch Stock
|
| Oct 22 |
P/E Ratio Insights for Abbott Laboratories
|
| Oct 21 |
Top Research Reports for Visa, Netflix & Merck
|
| Oct 21 |
Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation
|
| Oct 19 |
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
|
| Oct 18 |
Abbott Laboratories (ABT): Strong Q2 Performance and Innovative Product Approvals
|
| Oct 18 |
UBS upgrades view on U.S. stocks to attractive - here are its top picks
|
| Oct 18 |
Abbott Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations
|
